However, our study aimed to propose the perspective that PSMA-ligand-based risk model might have great potential for risk stratification and prediction of BCR after RP, as it could provide noninvasive and prospective information regarding tumor aggressiveness and prognosis. This evidence concerns the gene FOLH1 and neoplasm.